A patient's BNP comes back at 850 pg/mL but the chest X-ray looks clean. Does that rule out heart failure? Not even close — here's how to read the full diagnostic picture.
B-type natriuretic peptide (BNP) is the cornerstone lab for heart failure evaluation. Ventricular myocytes release BNP when wall stress increases from volume overload. A BNP below 100 pg/mL makes HF unlikely; above 400 pg/mL strongly supports the diagnosis. NT-proBNP uses different cutoffs — below 300 pg/mL helps rule out HF, while rule-in thresholds are age-stratified: >450 for age <50, >900 for age 50–75, and >1800 for age 75+. Obesity falsely lowers BNP, so a normal level in an obese client doesn't exclude HF. Renal failure falsely elevates it. Beyond BNP, echocardiography is the definitive diagnostic — it quantifies ejection fraction (EF), distinguishes systolic (EF ≤40%) from diastolic failure (EF ≥50%, preserved), and identifies valvular or structural causes. Chest X-ray findings include cardiomegaly, cephalization of pulmonary vessels, Kerley B lines, and pleural effusions. Basic metabolic panel matters because electrolyte imbalances (especially potassium, sodium, magnesium) guide medication safety. A low serum sodium (below 135 mEq/L) in HF signals dilutional hyponatremia from fluid overload and indicates worse prognosis.
Key Distinctions
Don't confuse BNP with troponin — BNP reflects ventricular stretch from volume/pressure overload, while troponin indicates myocardial cell death (MI). Students assume a normal BNP always rules out HF, but obesity suppresses BNP release, creating false negatives. Echocardiography determines the type of HF (systolic vs. diastolic); BNP cannot differentiate between them.
Clinical Pearl
Think of BNP as the ventricle's distress call — the more stretched the walls, the louder the signal. But a quiet signal in an obese patient doesn't mean no distress.